These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


219 related items for PubMed ID: 31921135

  • 21. CD4+ T helper cells and regulatory T cells in active lupus nephritis: an imbalance towards a predominant Th1 response?
    Mesquita D, Kirsztajn GM, Franco MF, Reis LA, Perazzio SF, Mesquita FV, Ferreira VDS, Andrade LEC, de Souza AWS.
    Clin Exp Immunol; 2018 Jan; 191(1):50-59. PubMed ID: 28945272
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Relevant genetic polymorphisms and kidney expression of Toll-like receptor (TLR)-5 and TLR-9 in lupus nephritis.
    Elloumi N, Fakhfakh R, Abida O, Ayadi L, Marzouk S, Hachicha H, Fourati M, Bahloul Z, Mhiri MN, Kammoun K, Masmoudi H.
    Clin Exp Immunol; 2017 Dec; 190(3):328-339. PubMed ID: 28763101
    [Abstract] [Full Text] [Related]

  • 24. Expression of CD64 on Surface of Circulating Monocytes in Systemic Lupus Erythematosus Patients: Relation to Disease Activity and Lupus Nephritis.
    Abd-Elhamid YA, Eltanawy RM, Fawzy RM, Fouad NA, Atlm AM.
    Egypt J Immunol; 2017 Jan; 24(1):67-78. PubMed ID: 29120579
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Low production of reactive oxygen species in granulocytes is associated with organ damage in systemic lupus erythematosus.
    Bengtsson AA, Pettersson Å, Wichert S, Gullstrand B, Hansson M, Hellmark T, Johansson ÅC.
    Arthritis Res Ther; 2014 Jun 05; 16(3):R120. PubMed ID: 24902963
    [Abstract] [Full Text] [Related]

  • 27. Upregulation of renal and systemic cyclooxygenase-2 in patients with active lupus nephritis.
    Tomasoni S, Noris M, Zappella S, Gotti E, Casiraghi F, Bonazzola S, Benigni A, Remuzzi G.
    J Am Soc Nephrol; 1998 Jul 05; 9(7):1202-12. PubMed ID: 9644630
    [Abstract] [Full Text] [Related]

  • 28. Heme oxygenase-1 production by peripheral blood monocytes during acute inflammatory illnesses of children.
    Yachie A, Toma T, Mizuno K, Okamoto H, Shimura S, Ohta K, Kasahara Y, Koizumi S.
    Exp Biol Med (Maywood); 2003 May 05; 228(5):550-6. PubMed ID: 12709585
    [Abstract] [Full Text] [Related]

  • 29. Decreased α7nAChR mRNA levels in peripheral blood monocytes are associated with enhanced inflammatory cytokine production in patients with lupus nephritis.
    Xu H, Li J, Zhang L, Li N, Su S, Ye Z, Xu Y.
    Biomed Pharmacother; 2019 Mar 05; 111():359-366. PubMed ID: 30594048
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Association of intrarenal B-cell infiltrates with clinical outcome in lupus nephritis: a study of 192 cases.
    Shen Y, Sun CY, Wu FX, Chen Y, Dai M, Yan YC, Yang CD.
    Clin Dev Immunol; 2012 Mar 05; 2012():967584. PubMed ID: 22792121
    [Abstract] [Full Text] [Related]

  • 32. The potential role of Th17 cells and Th17-related cytokines in the pathogenesis of lupus nephritis.
    Chen DY, Chen YM, Wen MC, Hsieh TY, Hung WT, Lan JL.
    Lupus; 2012 Nov 05; 21(13):1385-96. PubMed ID: 22892208
    [Abstract] [Full Text] [Related]

  • 33. Interleukin-32γ: Possible association with the activity and development of nephritis in patients with systemic lupus erythematosus.
    Kwon OC, Ghang B, Lee EJ, Hong S, Lee CK, Yoo B, Kim S, Kim YG.
    Int J Rheum Dis; 2019 Jul 05; 22(7):1305-1311. PubMed ID: 30941928
    [Abstract] [Full Text] [Related]

  • 34. Renal immunofluorescence and the prediction of renal outcome in patients with proliferative lupus nephritis.
    Nossent H, Berden J, Swaak T.
    Lupus; 2000 Jul 05; 9(7):504-10. PubMed ID: 11035415
    [Abstract] [Full Text] [Related]

  • 35. Co-Positivity for Anti-dsDNA, -Nucleosome and -Histone Antibodies in Lupus Nephritis Is Indicative of High Serum Levels and Severe Nephropathy.
    Yang J, Xu Z, Sui M, Han J, Sun L, Jia X, Zhang H, Han C, Jin X, Gao F, Liu Y, Li Y, Cao J, Ling H, Zhang F, Ren H.
    PLoS One; 2015 Jul 05; 10(10):e0140441. PubMed ID: 26465327
    [Abstract] [Full Text] [Related]

  • 36. Facilitated expansion of Th17 cells in lupus nephritis patients.
    Jakiela B, Kosałka J, Plutecka H, Bazan-Socha S, Sanak M, Musiał J.
    Clin Exp Immunol; 2018 Dec 05; 194(3):283-294. PubMed ID: 30086206
    [Abstract] [Full Text] [Related]

  • 37. Basophil involvement in lupus nephritis: a basis for innovation in daily care.
    Charles N, Chemouny JM, Daugas E.
    Nephrol Dial Transplant; 2019 May 01; 34(5):750-756. PubMed ID: 31009949
    [Abstract] [Full Text] [Related]

  • 38. Renal vascular lesions in lupus nephritis.
    Descombes E, Droz D, Drouet L, Grünfeld JP, Lesavre P.
    Medicine (Baltimore); 1997 Sep 01; 76(5):355-68. PubMed ID: 9352738
    [Abstract] [Full Text] [Related]

  • 39. Lupus nephritis: histopathologic features, classification and histologic scoring in renal biopsy.
    Dimitrijević J, Dukanović L, Kovacević Z, Bogdanović R, Maksić D, Hrvacević R, Aleksić A, Naumović R, Jovanović D, Brajusković G, Milosavljević I.
    Vojnosanit Pregl; 2002 Sep 01; 59(6 Suppl):21-31. PubMed ID: 12852143
    [Abstract] [Full Text] [Related]

  • 40. Podocytes and autophagy: a potential therapeutic target in lupus nephritis.
    Zhou XJ, Klionsky DJ, Zhang H.
    Autophagy; 2019 May 01; 15(5):908-912. PubMed ID: 30755075
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 11.